scroll down
Global API CDMO Company
Walking with partners,
Creating value
Creating value
Technology-driven gene therapy CDMO
from oligonucleotide to xRNA
View our Science & TechnologyGlobal API CDMO Company
Walking with Partners, Creating Value
Walking with Partners, Creating Value
30+years
Track record
40+
Global CDMO Project
6.4mole
Oligo CDMO Capacity ('22)
1.0kg / year
mRNA CDMO Capacity
IR Library
- [Presentation] ST PHARM mRNA platformMay 20, 2022
- [Presentation] ST PHARM IR Presentation (April 2022)May 9, 2022
- [Analyst Report] Focus on where it is headed, not where it is nowApr 29, 2022
- [Analyst Report] Bags major oligonucleotide drug dealMar 21, 2022
- [Analyst Report] Slips to operating loss due to costs, deferred oligo salesFeb 28, 2022